Tscan Therapeutics
Price & Volume
Stats
See more52W Range | $0.91-$4.93 |
Market Cap | $55.5M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $8.4M |
Revenue Growth (YoY) | 139.4% |
Gross Profit (12 Mos) | -$12.5M |
Diluted EPS | -$1.12 |
News
See moreYahoo Finance • 16 days ago
TScan Therapeutics GAAP EPS of -$0.28, revenue of $2.51M
Yahoo Finance • 25 days ago
TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027
Yahoo Finance • 2 months ago
TScan Therapeutics Announces Upcoming Oral and Poster Presentations at the American College of Rheumatology Convergence 2025
Yahoo Finance • 3 months ago
TScan Therapeutics to Participate in Upcoming Investor Conferences
About
CEO | Dr. Gavin MacBeath Ph.D. |
CFO | Mr. Jason A. Amello CPA |
Address | 830 Winter Street, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 146 |
